Value-Based Healthcare (VBHC): A game changer for pharma to accelerate patient access
A game changer for pharma to accelerate patient access
In today's rapidly evolving healthcare landscape, traditional models of delivering and accessing healthcare innovations are being challenged. The European Union’s Health Technology Assessment Regulation (HTAR) is undergoing significant changes, ushering in a new era for evaluating the effectiveness, safety, and value of healthcare technologies.